Skip to search formSkip to main contentSkip to account menu

Autologous Tumor Infiltrating Lymphocytes LN-144

Known as: Autologous TIL LN-144, LN-144 
A preparation of autologous tumor infiltrating lymphocytes (TILs), with potential antineoplastic activity. TILs are isolated from a patient's tumor… 
National Institutes of Health

Related topics

Related topics

5 relations
Antigen SensitizationCytotoxic T-LymphocytesNCIt Antineoplastic Agent TerminologyT-Cell Activation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
P865 Safety & efficacy of lifileucel (LN-144) tumor infiltrating lymphocyte therapy in metastatic melanoma patients after progression on multiple therapies – independent review committee data update
Background Treatment options are limited for patients with advanced melanoma who have progressed on checkpoint inhibitors and… 
2018
2018
A phase 2, multicenter study to assess the efficacy and safety of autologous tumor-infiltrating lymphocytes (LN-144) for the treatment of patients with metastatic melanoma.
TPS9595Background: Adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL) is recognized as an effective treatment… 
2018
2018
Abstract CT169: A phase II, multicenter study to assess the efficacy and safety of autologous tumor infiltrating lymphocytes (LN-144) for treatment of patients with metastatic melanoma
Adoptive cell therapy (ACT) utilizing tumor-infiltrating lymphocytes (TIL) has been employed for years in hundreds of patients… 
2017
2017
Efficacy of single administration of tumor-infiltrating lymphocytes (TIL) in heavily pretreated patients with metastatic melanoma following checkpoint therapy.
3045Background: Adoptive cell therapy with TIL involves collection of autologous lymphocytes from the tumor via surgical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)